UG1OD024950
Cooperative Agreement
Overview
Grant Description
The Oklahoma Pediatric Clinical Trials Network
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Oklahoma City,
Oklahoma
731043252
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/20 to 08/31/25 and the total obligations have increased 137% from $1,452,889 to $3,442,544.
University Of Oklahoma was awarded
The Oklahoma Pediatric Clinical Trials Network
Cooperative Agreement UG1OD024950
worth $3,442,544
from the National Institute of Allergy and Infectious Diseases in September 2016 with work to be completed primarily in Oklahoma City Oklahoma United States.
The grant
has a duration of 9 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Clinical Sites for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (UG1 Clinical Trial Required).
Status
(Ongoing)
Last Modified 9/5/24
Period of Performance
9/23/16
Start Date
8/31/25
End Date
Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
Activity Timeline
Transaction History
Modifications to UG1OD024950
Additional Detail
Award ID FAIN
UG1OD024950
SAI Number
UG1OD024950-3153859706
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75AGNA NIH AGGREGATE FINANCIAL ASSISTANCE DATA AWARDING OFFICE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
GY8NMUZQXVS7
Awardee CAGE
4B862
Performance District
OK-05
Senators
James Lankford
Markwayne Mullin
Markwayne Mullin
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $4,099,571 | 100% |
Modified: 9/5/24